K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Ross L. Levine
also known as L. Levine, Ross, Levine, Ross, Levine, Ross L.
Memorial Sloan Kettering Cancer Center · Northwestern University · Brigham and Women's Hospital · Novartis (Switzerland)
About this author
Works
1,469
Cited by
94,135
h-index
147
i10
500
ORCID ↗
Top papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu H. Estey, David Grimwade, et al.
·
2016
·
Blood
↗ 5,829
OA
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim, Craig H. Mermel, Dale Porter, et al.
·
2010
·
Nature
↗ 4,097
OA
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Ross L. Levine, Martha Wadleigh, Jan Cools, et al.
·
2005
·
Cancer Cell
↗ 2,984
OA
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Hartmut Döhner, Andrew H. Wei, Frederick R. Appelbaum, et al.
·
2022
·
Blood
↗ 2,869
OA
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
María E. Figueroa, Omar Abdel‐Wahab, Chao Lü, et al.
·
2010
·
Cancer Cell
↗ 2,723
OA
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Şevin Turcan, Daniel Rohle, Anuj Goenka, et al.
·
2012
·
Nature
↗ 1,981
OA
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward, Jay Patel, David R. Wise, et al.
·
2010
·
Cancer Cell
↗ 1,971
OA
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lü, Patrick S. Ward, Gurpreet S. Kapoor, et al.
·
2012
·
Nature
↗ 1,958
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel, Mithat Gönen, María E. Figueroa, et al.
·
2012
·
New England Journal of Medicine
↗ 1,939
OA
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar, Kristen E. Stevenson, Omar Abdel‐Wahab, et al.
·
2011
·
New England Journal of Medicine
↗ 1,618
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea, et al.
·
2017
·
Blood
↗ 1,452
OA
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Yana Pikman, Benjamin H. Lee, Thomas Mercher, et al.
·
2006
·
PLoS Medicine
↗ 1,410
OA